2,2'-dithiodiethanesulfonic acid and paclitaxel

2,2'-dithiodiethanesulfonic acid has been researched along with paclitaxel in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Senior, K	1
Hausheer, F; Murphy, M; Pendyala, L; Schwartz, G; Smith, P; Zdanowicz, J	1
Fukuoka, M; Hausheer, F; Kudoh, S; Masuda, N; Matsui, K; Nakagawa, K; Negoro, S; Ohashi, Y; Takeda, K; Yamamoto, N; Yoshimura, N	1
Hausheer, FH; Kochat, H; Parker, AR; Petluru, PN; Wu, M; Zhao, M	1

Trials

1 trial(s) available for 2,2'-dithiodiethanesulfonic acid and paclitaxel

Article	Year
Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Mesna; Middle Aged; Neoplasm Staging; Paclitaxel; Treatment Outcome	2011

Article

Year

Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer.

Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Mesna; Middle Aged; Neoplasm Staging; Paclitaxel; Treatment Outcome

2011

Other Studies

3 other study(ies) available for 2,2'-dithiodiethanesulfonic acid and paclitaxel

Article	Year
Supercomputer-designed drug protects against chemotherapy toxicity. The Lancet. Oncology, 2000, Volume: 1 Topics: Breast Neoplasms; Central Nervous System Diseases; Computer-Aided Design; Controlled Clinical Trials as Topic; Drug Design; Drug Interactions; Female; Humans; Mesna; Paclitaxel	2000
Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy. Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cisplatin; Cysteine; Disulfides; Glutathione; Half-Life; Humans; Infusions, Intravenous; Kinetics; Mesna; Neoplasms; Paclitaxel; Sulfhydryl Compounds	2003
BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro. Molecular cancer therapeutics, 2010, Volume: 9, Issue:9 Topics: Animals; Antineoplastic Agents; Cattle; Cisplatin; Drug Interactions; Mesna; Microtubule Proteins; Microtubules; Paclitaxel; Polymerization	2010